Search bioRxiv⌕ Search

Biology subjects

Tetreault, P.

Publications and source records attributed to Tetreault, P..

2 recordsLinked to original sources

Spatiotemporal Gray Matter Plasticity During Chronification of Preclinical Neuropathic Pain

Chronic neuropathic pain is increasingly recognized as a brain disease characterized by time-dependent structural and functional reorganization of key neural circuits. While human imaging studies implicate widespread changes in network connectivity and gray matter density (GMD), animal models enable direct longitudinal mapping of such plasticity. Here, we applied high-resolution structural MRI in a rat model of chronic pain (spared nerve injury, SNI) and quantified GMD changes across 134 brain regions. Dynamic weight bearing analysis confirmed persistent pain in SNI rats, validating the chronic pain phenotype in our experimental cohort. Longitudinal MRI revealed significant GMD alterations in 31 regions, predominantly within limbic, prefrontal, and cingulate circuits, representing 21% of total brain volume. Among this affected volume, over 17% of brain volume demonstrated GMD increases while only ~3% showed GMD decreases, indicating a heterogeneous neuroplastic response. Specifically, the Frontal Association Cortex exhibited an approximate 10% increase in GMD, the Primary Cingular Cortex showed a modest increase of about 2%, and the Amygdalohyppocampic Area demonstrated a ~10% decrease in GMD over 28 days. Primary sensory, parietal, visual, retrosplenial, and temporal cortices remained largely unaffected. No significant changes were observed in healthy animals over the same period, highlighting the specificity of brain reorganization to persistent neuropathic pain. These findings reaffirm the ability of MRI to robustly quantify pain-induced neuroanatomical remodeling but leave open critical questions about the underlying cellular and molecular mechanisms. Future studies integrating histological and molecular approaches are needed to determine the precise substrate and reversibility of these structural changes, with the goal of identifying therapeutic targets to prevent or reverse maladaptive neuroplasticity in chronic.

neuroscience↗

Analgesic effects of neurotensin agonists in a rat bone cancer pain model

Bone metastases are a source of intractable pain, resistant to conventional opioid and non-opioid analgesics. The neurotensin system represents a potential pathway toward bone cancer pain (BCP) relieve via the inhibition of its receptors NTS1 and NTS2. Capitalizing on our recent results using neurotensin analogs in inflammatory and neuropathic pain models, we here show, for the first time, a potential role for neurotensin receptors agonists in the treatment of BCP. The novel non-selective agonist JMV-2009 (300 g/kg) reversed mechanical allodynia in our rodent BCP model at both early and late stages of the disease. The NTS2-selective agonist JMV-431 (90 g/kg), in addition to anti-allodynia, also had an effect on weight bearing deficits. In parallel, we tested proven analgesics from several classes to put the effect of neurotensin analogs in perspective and found that morphine (3 mg/kg), tramadol (15 mg/kg) and amitriptyline (10 mg/kg) had mild effects on BCP while the cannabinoid nabilone (1 mg/kg) significantly reversed both allodynia and weight bearing deficits. Taken together, our results affirm the potential of the modulation of the neurotensin system for the development of new analgesics for the treatment of bone cancer pain.

pharmacology and toxicology↗